CENCORA, INC. for CENCORA, INC.
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Ensuring Community Access to Pharmacist Services Act (H.R. 3164)/ Main Street Pharmacy Access Act (H.R. 3164)/ Equitable Community Access to Pharmacist Services Act (S.2426) Inflation Reduction Act implementation, including impact on Pharmacy & Physician Reimbursement Protecting Patient Access to Cancer and Complex Therapies Act 2025 (H.R 4299) Reimbursement policies impacting drug shortages Part B drug pricing changes Preventing and mitigating generic drug shortages CMS FY 2026 Medicare Part B Physician Fee Schedule Medicare physician reimbursement CY2026 Medicare Physician Fee Schedule Rule CMS FY 2027 Medicare Physician Fee Schedule Distributor bona fide service fees Patients First Act of 2026 (H.R.9693)
| Lobbyist | Covered position, as disclosed |
|---|---|
| FREDERICK ESSIS | — |
| COREY AUSTIN MCGEE | — |
| VIVIENNE STAFFORD MITCHELL | — |
| SHELLY MUI-LIPNIK | — |
| DARRELL ROGERS | — |
Pharmacy PHA
Preventing and mitigating generic drug shortages Ensuring Seniors Access to Critical Medications Act/ Main Street Pharmacy Access Act (H.R. 3164)/Equitable Community Access to Pharmacist Services Act (S.2426) Impacts to pharmacy Part D drug pricing in Inflation Reduction Act (IRA) Support for Fair Pharmacy Reimbursement
| Lobbyist | Covered position, as disclosed |
|---|---|
| FREDERICK ESSIS | — |
| COREY AUSTIN MCGEE | — |
| VIVIENNE STAFFORD MITCHELL | — |
| SHELLY MUI-LIPNIK | — |
| DARRELL ROGERS | — |
Health Issues HCR
Essential Medicines Strategic Stockpile Department of Defense Essential Medicines Strategic Stockpile Prescription Information Modernization Act (H.R.4132/S.2027) Mitigation of Drug Shortages Pharmaceutical supply chain resilience National Defense Authorization Act for Fiscal Year 2027 (NDAA - H.R.8800/S.4784) Supply Chain Resiliency Most Favored Nation drug pricing proposals Direct to consumer pharmacy proposals CMS FY 2026 Medicare Part B Physician Fee Schedule Rule Break Up Big Medicine Act (S. 3822) Stop Corporate Take Over of Physicians Act (H.R.10444/S.5419) Role and value of community specialty physicians and Management Services Organizations (MSOs) NIH Restructuring/National Eye Institute Pandemic and All-Hazards Preparedness/Protecting Americans from All Hazards Preparedness Act (PAHPA) Protecting Patient Access to Cancer and Complex Therapies Act (H.R. 4299)
| Lobbyist | Covered position, as disclosed |
|---|---|
| FREDERICK ESSIS | — |
| COREY AUSTIN MCGEE | — |
| VIVIENNE STAFFORD MITCHELL | — |
| SHELLY MUI-LIPNIK | — |
| DARRELL ROGERS | — |
Taxation/Internal Revenue Code TAX
Net CFC Tested Income (NCTI) US Territories Reshoring Tax Policy
| Lobbyist | Covered position, as disclosed |
|---|---|
| FREDERICK ESSIS | — |
| COREY AUSTIN MCGEE | — |
| VIVIENNE STAFFORD MITCHELL | — |
| SHELLY MUI-LIPNIK | — |
| DARRELL ROGERS | — |
Trade (domestic/foreign) TRD
Tariff proposed policies H.R.2213 - Medical Supply Chain Resiliency Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| FREDERICK ESSIS | — |
| COREY AUSTIN MCGEE | — |
| VIVIENNE STAFFORD MITCHELL | — |
| SHELLY MUI-LIPNIK | — |
| DARRELL ROGERS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.